Public list: Pharma Startups (4733)
Palatin Technologies is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and ...Show all
Company (IPO / Went public)
Phone: 609-495-2200
4-B Cedar Brook Drive
Cedar Brook Corporate Center
Cranbury, 08512
New Jersey, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| Palatin Technologies | $109.9M | Apr 12, 2006 |
| Pharmaceutical Product Development | $82.5M | Apr 27, 2017 |
| Biolog | $0M | Aug 7, 2018 |
| See all 15 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Uses of bremelanotide in therapy for female sexual dysfunction | May 05, 2015 | Jul 11, 2017 | Patent |
| Melanocortin-1 receptor-specific linear peptides | Dec 30, 2014 | Feb 28, 2017 | Patent |
| Melanocortin receptor-specific heptapeptides | Jul 11, 2014 | Oct 04, 2016 | Patent |
| Uses of bremelanotide in therapy for female sexual dysfunction | Jun 24, 2014 | May 31, 2016 | Patent |
| Peptidomimetics of biologically active metallopeptides | Feb 10, 2004 | Oct 05, 2010 | Patent |
Download PDF